Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aksense is a private medtech diagnostics company developing portable biosensor-based tests for rapid detection of healthcare-associated and other infectious diseases. The company appears focused on point-of-care blood testing and nucleic acid-based diagnostic panels intended to identify pathogens quickly without complex centralized laboratory workflows. Its technology is positioned to improve early diagnosis, support antibiotic stewardship, and reduce delays in treatment for hospital-acquired infections. Publicly available information suggests the business is still in product development and commercialization build-out rather than commercial stage. The company has been described as operating from Turkey and the UK and has raised seed and later-stage venture financing from investors including SOSV.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aksense.